Lygos uses microbugs to transform small-expense sugar into specialty chemicals utilised in manufacturing and is now releasing a strategy to make malic acid, an ingredient desired in the mass manufacturing of electronics. To do so, the business announced nowadays it has lifted $13 million in Series A funding direct by OS Fund and IA Ventures, with participation from To start with Round Capital, Y Combinator’s Continuity Fund, Fifty Yrs, Large Ventures, and many angel investors. There are a couple of biotech startups that have begun to pop up in the chemical manufacturing area these as New Light-weight Technologies, Biomethodes and Ginkgo Bioworks. Each has a specialty — Ginkgo focuses on building scents and flavors utilizing microorganisms, for instance. Lygos pioneered a strategy to use microbugs to make specialised chemical substances instead of the oil-based mostly petrochemicals usually utilised in the marketplace. The startup engineers its exclusive microbes to produce the chemical substances in-dwelling, combining application and new biochemistry know-how to make its materials at scale and tells TechCrunch it begun delivery the very first bio-malonic acid-making microbes to shoppers. Jeffrey Klunzinger, taking care of associate at enterprise capital company OS Fund equated Lygos’ work with the Industrial Revolution, stating his company invested in the startup since of its fascination in the area and Lygos one of a kind know-how, “Lygos uniquely has the know-how to produce a secure offer of industrial chemical substances with no environmental impact and at reduced expense. They are building much better products that are cleanse, sustainable and have expense and quality benefits about their petrochemical counterparts.” Lygos is now making “metric ton quantities” of its bio-malonic acid products and states it programs to use the new funding to “enter this subsequent section of progress and keep on building our workforce, our manufacturing, and QC infrastructure, all when delivering additional gas for our innovation motor to acquire the subsequent new products utilizing our microbial manufacturing know-how.”
Showcased Picture: Faris Algosaibi/Flickr Below A CC BY two. LICENSE
Source website link Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on Google+ (Opens in new window)
Related
Lygos uses microbugs to transform small-expense sugar into specialty chemicals utilised in manufacturing and is now releasing a strategy to make malic acid, an ingredient desired in the mass manufacturing of electronics. To do so, the business announced nowadays it has lifted $13 million in Series A funding direct by OS Fund and IA Ventures, with participation from To start with Round Capital, Y Combinator’s Continuity Fund, Fifty Yrs, Large Ventures, and many angel investors. There are a couple of biotech startups that have begun to pop up in the chemical manufacturing area these as New Light-weight Technologies, Biomethodes and Ginkgo Bioworks. Each has a specialty — Ginkgo focuses on building scents and flavors utilizing microorganisms, for instance. Lygos pioneered a strategy to use microbugs to make specialised chemical substances instead of the oil-based mostly petrochemicals usually utilised in the marketplace. The startup engineers its exclusive microbes to produce the chemical substances in-dwelling, combining application and new biochemistry know-how to make its materials at scale and tells TechCrunch it begun delivery the very first bio-malonic acid-making microbes to shoppers. Jeffrey Klunzinger, taking care of associate at enterprise capital company OS Fund equated Lygos’ work with the Industrial Revolution, stating his company invested in the startup since of its fascination in the area and Lygos one of a kind know-how, “Lygos uniquely has the know-how to produce a secure offer of industrial chemical substances with no environmental impact and at reduced expense. They are building much better products that are cleanse, sustainable and have expense and quality benefits about their petrochemical counterparts.” Lygos is now making “metric ton quantities” of its bio-malonic acid products and states it programs to use the new funding to “enter this subsequent section of progress and keep on building our workforce, our manufacturing, and QC infrastructure, all when delivering additional gas for our innovation motor to acquire the subsequent new products utilizing our microbial manufacturing know-how.”
Showcased Picture: Faris Algosaibi/Flickr Below A CC BY two. LICENSE
Lygos uses microbugs to transform small-expense sugar into specialty chemicals utilised in manufacturing and is now releasing a strategy to make malic acid, an ingredient desired in the mass manufacturing of electronics.
To do so, the business announced nowadays it has lifted $13 million in Series A funding direct by OS Fund and IA Ventures, with participation from To start with Round Capital, Y Combinator’s Continuity Fund, Fifty Yrs, Large Ventures, and many angel investors.
There are a couple of biotech startups that have begun to pop up in the chemical manufacturing area these as New Light-weight Technologies, Biomethodes and Ginkgo Bioworks.
Each has a specialty — Ginkgo focuses on building scents and flavors utilizing microorganisms, for instance. Lygos pioneered a strategy to use microbugs to make specialised chemical substances instead of the oil-based mostly petrochemicals usually utilised in the marketplace.
The startup engineers its exclusive microbes to produce the chemical substances in-dwelling, combining application and new biochemistry know-how to make its materials at scale and tells TechCrunch it begun delivery the very first bio-malonic acid-making microbes to shoppers.
Jeffrey Klunzinger, taking care of associate at enterprise capital company OS Fund equated Lygos’ work with the Industrial Revolution, stating his company invested in the startup since of its fascination in the area and Lygos one of a kind know-how, “Lygos uniquely has the know-how to produce a secure offer of industrial chemical substances with no environmental impact and at reduced expense. They are building much better products that are cleanse, sustainable and have expense and quality benefits about their petrochemical counterparts.”
Lygos is now making “metric ton quantities” of its bio-malonic acid products and states it programs to use the new funding to “enter this subsequent section of progress and keep on building our workforce, our manufacturing, and QC infrastructure, all when delivering additional gas for our innovation motor to acquire the subsequent new products utilizing our microbial manufacturing know-how.”
Showcased Picture: Faris Algosaibi/Flickr Below A CC BY two. LICENSE